Status:
COMPLETED
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study examines the efficacy of the medication D-Cycloserine in the reduction of obsessions and compulsions in individuals with obsessive-compulsive disorder (OCD). All study participants will rec...
Detailed Description
The study consists of Behavior Therapy (Exposure and Response Prevention; ERP) for OCD. Specifically, it involves exposure to anxiety-provoking situations and response-prevention of any rituals. ERP h...
Eligibility Criteria
Inclusion
- Meets diagnosis for obsessive-compulsive disorder
Exclusion
- History of psychotic disorders
- History of neurological disorders
- History of bipolar disorders
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00126282
Start Date
December 1 2003
End Date
December 1 2007
Last Update
July 29 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Anxiety Disorders Center, The Institute of Living
Hartford, Connecticut, United States, 06106
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114